Clinical Trial Update: A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis [Phase 2]

View source ↗

Summary

A phase 2 trial of BI 3032950 for ulcerative colitis is ongoing, and the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BI 3032950

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Ulcerative Colitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING